EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIF14–AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer

Chunyu Shi, Weiyi Fang, Yingqi Zhu, Ziying Xie, Ming Zhang

Open Life Sciences · 23.01.2026 · 21 (1)

DOI: 10.1515/biol-2025-1324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Life Sciences, online erschienen am 04.05.2026. Verfasst von Chunyu Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yunkang School of Medicine and Health, Guangzhou Nanfang College, Guangzhou 510080, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited targeted treatment options. Ferroptosis has emerged as a potential therapeutic vulnerability in TNBC, but its upstream regulation remains incompletely defined. Here, we combined bioinformatics analysis with cell-based experiments to investigate the role of kinesin family member 14 (KIF14) in ferroptosis sensitivity. KIF14 was upregulated in TNBC datasets and associated with poor prognosis. In MDA-MB-468 cells, KIF14 knockdown reduced cell viability, increased malondialdehyde and intracellular Fe 2+ levels, and induced mitochondrial changes consistent with ferroptosis. These effects were partially reversed by ferrostatin-1. Comparison with inhibitors of apoptosis, necroptosis, and pyroptosis showed that only ferrostatin-1 produced a clear rescue effect, supporting a predominantly ferroptosis-associated phenotype. Mechanistically, KIF14 depletion reduced phosphorylation of AKT serine/threonine kinase (AKT) and altered ferroptosis-related proteins, including decreased glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11) and increased acyl-CoA synthetase long-chain family member 4 (ACSL4). The AKT activator SC79 partially reversed these biochemical and phenotypic changes. Reciprocal co-immunoprecipitation further supported an association between endogenous KIF14 and AKT. In addition, KIF14 knockdown had minimal effects on the viability of normal MCF-10A cells. Together, these findings support a functional link between KIF14, AKT signaling, and ferroptosis sensitivity in TNBC .

Schlagwörter

Stichwörter der Autor:innen

AKTKIF14ferroptosistherapeutic targettriple-negative breast cancer

Autor:innen und Institutionen

  • Yunkang School of Medicine and Health, Guangzhou Nanfang College, Guangzhou 510080, China.

Zitieren

APA

Shi, C., Fang, W., Zhu, Y., Xie, Z., & Zhang, M. (2026). KIF14–AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer. Open Life Sciences, 21(1). https://doi.org/10.1515/biol-2025-1324

Vancouver

Shi C, Fang W, Zhu Y, Xie Z, Zhang M. KIF14–AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer. Open Life Sciences. 2026;21(1). doi:10.1515/biol-2025-1324

BibTeX
@article{Shi2026,
  author = {Shi, Chunyu and Fang, Weiyi and Zhu, Yingqi and Xie, Ziying and Zhang, Ming},
  title = {KIF14–AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer},
  journal = {Open Life Sciences},
  year = {2026},
  volume = {21},
  number = {1},
  doi = {10.1515/biol-2025-1324}
}
Kostenlos starten →